CorMedix, Inc. (CRMD)
7.935
+0.12
(+1.47%)
USD |
NASDAQ |
May 20, 16:00
7.85
-0.08
(-1.07%)
After-Hours: 07:35
CorMedix EPS Diluted (Quarterly) : 0.4151 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.4688 |
| Eli Lilly & Co. | 8.255 |
| Theravance Biopharma, Inc. | -0.0962 |
| Hyperion DeFi, Inc. | 0.255 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 38.60M |
| Revenue (Quarterly) | 127.43M |
| Total Expenses (Quarterly) | 88.83M |
| Enterprise Value | 579.64M |
| Gross Profit Margin (Quarterly) | 82.50% |
| Profit Margin (Quarterly) | 30.29% |
| Earnings Yield | 26.46% |
| Operating Earnings Yield | 28.30% |
| Normalized Earnings Yield | 27.29 |